- Published: 18 March 2015
SPRINGFIELD – What do you do when you are convinced that you have found a lump in your breast, but doctors fail to see it? It is an incredibly frustrating and frightening position to be in, and it is one with which Jennifer Hoeft and Linda Racki are both intimately familiar.
Hoeft and Racki, both of Peoria, shared similar experiences. For one woman, she was convinced she had developed a tumor and wanted it out. Traditional methods for detection failed to spot the growth. For the other, years of routine mammographies revealed no growths. For both women, tomosynthesis was the saving grace in their diagnosis and eventual treatment.
Tomosynthesis is better known as 3D mammography, and it differs from standard mammograms in that it has the ability to better detect growths in dense breast tissue that often go unseen. Imagine the difference between looking at and understanding a book by its covers versus actually reading each page.
The technology reduces false positives, greatly increases the visibility to sense invasive cancers and reduces cost to patients and hospitals. SB 54 would add tomosynthesis to the list of insured low-dose mammograms. The proposal is sponsored by Senator John Mulroe (D-Chicago).
“If there is a better way to do something, we very much should be doing it,” Mulroe said. “These 3D mammograms have the ability to save more lives while reducing the pain of an arduous diagnosis. This is a common-sense bill.”
The measure passed favorably out of committee today and now moves to the Senate floor for further debate.
Hear Jennifer Hoeft in her own words:
Hear Linda Racki in her own words: